Navigating postpartum psychosis: strategies for timely diagnosis and effective treatment

This article outlines postpartum psychosis (PPP), a severe mental health condition that manifests shortly after childbirth, characterized by sudden onset of affective and psychotic symptoms. With a global prevalence of 1–3 per 1,000 births, PPP is considered a psychiatric emergency requiring prompt intervention to prevent dire outcomes like suicide or infanticide. Early detection and comprehensive treatment are crucial for safeguarding both mother and infant.

PPP is typically associated with a history of bipolar disorder, making it part of the bipolar spectrum, though it is yet to be formally recognized as a distinct diagnostic entity. Common symptoms include confusion, mood fluctuations, hallucinations, and delusional beliefs, often involving the infant. Risk factors span personal or family history of bipolar disorder, primiparity, and sleep deprivation during labor.

Management strategies prioritize inpatient care, ideally in a mother-baby unit (MBU), where specialized treatment can support maternal recovery while ensuring infant safety. The primary treatment involves pharmacological therapy, notably antipsychotics and lithium, which shows strong evidence for relapse prevention. Electroconvulsive therapy (ECT) may be considered for rapid symptom control in severe or treatment-resistant cases.

Breastfeeding and medication choices require careful consideration due to potential drug transmission to the infant. Psychoeducation, family support, and ongoing risk assessment are essential parts of the care plan to enhance maternal-infant bonding and prevent future episodes. Early and effective treatment leads to favorable long-term outcomes, emphasizing the need for increased awareness and tailored care protocols.